Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Coloring and VR calm Moms-to-Be during baby heart monitoring

NCT ID NCT07030530

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study looked at whether watching a virtual reality video or coloring a mandala pattern could help pregnant women feel less anxious during a Non-Stress Test (NST), a common check on baby's health. 108 pregnant women took part, and researchers measured their anxiety, satisfaction, and test results. The goal was to find simple, drug-free ways to make the test more comfortable and improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

Jun 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: To be over 18 years of age, * Not having any chronic or metabolic disease (completely healthy pregnant women) * Not having any psychiatric illne Exclusion Criteria: * -Multiple pregnancy * Contraction on NST communication and visual impairment, uterine contraction as a result of NST, * Have any chronic disease (such as diabetes mellitus, hypertension, heart failure), * Have pregnancy complications (such as pre-eclampsia, gestational diabetes, Rh incompatibility), * History of infertility and conceived with assisted reproductive techniques, * The fetus has an identified problem (such as anomaly, intrauterine growth retardation and cardiovascular disease), * Pregnant women who provided false or incomplete information were excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kahramanmaraş Sütçü İmam Üniversitesi

    Kahramanmaraş, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.